BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 30183091)

  • 1. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma.
    Wahn U; Bachert C; Heinrich J; Richter H; Zielen S
    Allergy; 2019 Mar; 74(3):594-604. PubMed ID: 30183091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis.
    Zielen S; Devillier P; Heinrich J; Richter H; Wahn U
    Allergy; 2018 Jan; 73(1):165-177. PubMed ID: 28561266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of pollen allergoid tyrosine-adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma.
    Vogelberg C; Klimek L; Kruppert S; Becker S
    Clin Exp Allergy; 2024 Apr; 54(4):253-264. PubMed ID: 38146840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma.
    Vogelberg C; Brüggenjürgen B; Richter H; Jutel M
    Patient Prefer Adherence; 2020; 14():817-827. PubMed ID: 32494127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France.
    Devillier P; Molimard M; Ansolabehere X; Bardoulat I; Coulombel N; Maurel F; Le Jeunne P; Demoly P
    Allergy; 2019 Jul; 74(7):1317-1326. PubMed ID: 30589088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma.
    Jutel M; Brüggenjürgen B; Richter H; Vogelberg C
    Allergy; 2020 Aug; 75(8):2050-2058. PubMed ID: 32080856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
    Jutel M; Klimek L; Richter H; Brüggenjürgen B; Vogelberg C
    Allergy; 2024 Apr; 79(4):1042-1051. PubMed ID: 38429981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma.
    Pfaar O; Bachert C; Kuna P; Panzner P; Džupinová M; Klimek L; van Nimwegen MJ; Boot JD; Yu D; Opstelten DJE; de Kam PJ
    J Allergy Clin Immunol; 2019 Mar; 143(3):970-977. PubMed ID: 30508538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis.
    Yang J; Lei S
    Front Immunol; 2023; 14():1274241. PubMed ID: 38162647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.
    Creticos PS; Gunaydin FE; Nolte H; Damask C; Durham SR
    J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1415-1427. PubMed ID: 38685477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study.
    Contoli M; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Fritzsching B
    J Allergy Clin Immunol; 2023 Aug; 152(2):445-452.e4. PubMed ID: 36871918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Development Forms of Local Allergic Rhinitis towards Birch.
    Bozek A; Winterstein J; Galuszka B; Jarzab J
    Biomed Res Int; 2020; 2020():3408561. PubMed ID: 32596297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Safe and Effective Sublingual Birch Allergen Immunotherapy in Two HIV-Positive Patients.
    Latysheva E; Nazarova E; Latysheva T; Ilina N
    Front Immunol; 2021; 12():599955. PubMed ID: 34385997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment.
    Rodríguez Del Río P; Vidal C; Just J; Tabar AI; Sanchez-Machin I; Eberle P; Borja J; Bubel P; Pfaar O; Demoly P; Calderón MA
    Pediatr Allergy Immunol; 2017 Feb; 28(1):60-70. PubMed ID: 27637414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world evidence for the long-term effect of allergen immunotherapy: Current status on database-derived European studies.
    Vogelberg C; Klimek L; Brüggenjürgen B; Jutel M
    Allergy; 2022 Dec; 77(12):3584-3592. PubMed ID: 36074052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170(3):635-667. PubMed ID: 38408153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170 Suppl 1():S1-S42. PubMed ID: 38408152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study.
    Khinchi MS; Poulsen LK; Carat F; André C; Hansen AB; Malling HJ
    Allergy; 2004 Jan; 59(1):45-53. PubMed ID: 14674933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.